Newark, CA, United States of America

Johan Borglin

This inventor holds 1 USPTO granted patent. Top assignee: Eyeque Corporation. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Johan Borglin in Vision Measurement Technology

Introduction

Johan Borglin is an innovative inventor based in Newark, CA, who has made significant contributions to the field of vision measurement technology. His work focuses on developing consumer products that enable individuals to track their vision without the need for professional eye care visits.

Latest Patents

Borglin holds a patent for a "Method and apparatus for refraction and vision measurement." This invention allows consumers to obtain refraction measurements using devices that can work in conjunction with smartphones or other touchscreen products. The technology is designed to present images to refraction measurement devices, facilitating a more accessible way for users to monitor their vision.

Career Highlights

Johan Borglin is associated with Eyeque Corporation, where he applies his expertise in developing innovative solutions for vision measurement. His patent addresses the challenges of unknown resolution rates in smartphones, which can affect the accuracy of vision assessments. The invention includes an optical interface that helps users align their smartphone's view port with that of the refraction measurement device, enhancing the user experience.

Collaborations

Borglin collaborates with talented individuals such as Noam Sapiens and John Serri, contributing to a dynamic work environment at Eyeque Corporation. Their combined efforts aim to push the boundaries of consumer vision technology.

Conclusion

Johan Borglin's contributions to vision measurement technology exemplify the potential of innovative solutions in enhancing consumer health. His patent not only simplifies the process of tracking vision but also empowers users to take charge of their eye care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…